| Alpa Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532878 |
NSE Symbol : ALPA |
P/E(TTM) : 10.69 |
|
ISIN Demat : INE385I01010 |
Div & Yield% : 0.00 |
EPS(TTM) : 5.61 |
|
Book Value(₹) : 92.05 |
Market Cap(₹Cr) : 126.22 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 29.67 | 25.63 | 19.11 | 39.11 | 26.15 | 24.94 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 29.67 | 25.63 | 19.11 | 39.11 | 26.15 | 24.94 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.26 | 3.69 | 11.96 | 3.24 | 8.80 | 6.91 |
| Total Income | 29.93 | 29.32 | 31.07 | 42.35 | 34.95 | 31.85 |
| Total Expenditure | 27.53 | 28.50 | 18.69 | 39.47 | 25.41 | 21.67 |
| PBIDT | 2.40 | 0.82 | 12.38 | 2.88 | 9.54 | 10.18 |
| Interest | 0.03 | 0.05 | 0.05 | 0.05 | 0.10 | 0.06 |
| PBDT | 2.37 | 0.77 | 12.33 | 2.83 | 9.44 | 10.12 |
| Depreciation | 0.65 | 0.67 | 0.55 | 0.58 | 0.55 | 0.53 |
| Tax | -0.16 | 0.00 | 0.00 | 2.10 | 0.00 | 1.96 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 2.10 | 0.00 | 0.00 |
| Reported Profit After Tax | 1.87 | 0.10 | 11.78 | -1.95 | 8.89 | 7.63 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1.87 | 0.10 | 11.78 | -1.95 | 8.89 | 7.63 |
| EPS (Unit Curr.) | 0.89 | 0.05 | 5.60 | -0.86 | 4.24 | 3.63 |
| EPS (Adj) (Unit Curr.) | 0.89 | 0.05 | 5.60 | -0.86 | 4.24 | 3.63 |
| Calculated EPS (Unit Curr.) | 0.89 | 0.05 | 5.60 | -0.93 | 4.23 | 3.63 |
| Calculated EPS (Adj) (Unit Curr.) | 0.89 | 0.05 | 5.60 | -0.93 | 4.23 | 3.63 |
| Calculated EPS (Ann.) (Unit Curr.) | 3.56 | 0.19 | 22.39 | -3.70 | 16.91 | 14.50 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 3.56 | 0.19 | 22.39 | -3.70 | 16.91 | 14.50 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 21.04 | 21.04 | 21.04 | 21.04 | 21.04 | 21.04 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 8.09 | 3.20 | 64.78 | 7.36 | 36.48 | 40.82 |
| PBDTM(%) | 7.99 | 3.00 | 64.52 | 7.24 | 36.10 | 40.58 |
| PATM(%) | 6.30 | 0.39 | 61.64 | -4.99 | 34.00 | 30.59 |
